✦ LIBER ✦

STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia

✍ Scribed by Michael E O'Dwyer; Brian J Druker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synergistic activity of the new ABL-spec

✍ Topaly, J; Zeller, W J; Fruehauf, S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

The in vitro activity of the tyrosine ki

✍ Liu, W M; Stimson, L A; Joel, S P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

STI571, a tyrosine kinase inhibitor for

✍ Michael J. Mauro; Michael E. O'Dwyer; Brian J. Druker 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 66 KB

Multiple BCR-ABL kinase domain mutations

✍ Neil P. Shah; John M. Nicoll; Bhushan Nagar; Mercedes E. Gorre; Ronald L. Paquet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Mechanisms of BCR–ABL in the pathogenesi

✍ Ren, Ruibao 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 291 KB

Tyrosine kinase inhibitor STI571 in the

✍ Au, W Y; Lie, A K W; Ma, S K; Wan, T S; Liang, R; Chan, E C; Kwong, Y L 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB